glp-1 receptor antagonist GIPR antibodies conjugated to peptide are bispecific molecules that decrease weight in obese mice and monkeys Emerging Nondopaminergic Medications for Parkinson's

Cost and Accessibility GLP-1s can be expensivesometimes $1,000+ per month without insurance

We utilize High-Performance Liquid Chromatography (HPLC) to verify an absolute chemical purity profile of 99% or greater

Gonzalez-Garcia I, Gruber T, Garcia-Caceres C

Important Context Successful weight reduction in any protocol requires: Caloric control Adequate protein intake Resistance training Sleep optimisation Peptides modulate pathways they do not replace foundational variables

Notably, tirzepatide is characterised in the literature as an imbalanced or biased dual agonist: its affinity for the GIP receptor is comparable to native GIP, while its affinity for the GLP-1 receptor is roughly 18- to 20-fold weaker than native GLP-1